# Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors

> **NCT00031798** · PHASE3 · TERMINATED · sponsor: **Wake Forest University Health Sciences**

## Conditions studied

- Brain and Central Nervous System Tumors
- Cognitive/Functional Effects
- Depression
- Fatigue
- Quality of Life

## Interventions

- **DRUG:** methylphenidate hydrochloride
- **PROCEDURE:** quality-of-life assessment
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00031798
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-04-01
- **Primary completion:** 2005-03-01
- **Final completion:** 2006-05-01
- **Target enrollment:** — (—)
- **Why stopped:** low accrual; loss of funding
- **Last updated:** 2021-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00031798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00031798, "Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00031798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*